Your browser doesn't support javascript.
loading
Factors associated with refractoriness or early progression after idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma: U.S. Myeloma Immunotherapy Consortium real world experience.
Hashmi, Hamza; Hansen, Doris K; Peres, Lauren C; Puglianini, Omar Castaneda; Freeman, Ciara; De Avila, Gabriel; Sidana, Surbhi; Shune, Leyla; Sborov, Douglas W; Davis, James; Wagner, Charlotte; Kocoglu, Mehmet H; Atrash, Shebli; Voorhees, Peter; Simmons, Gary; Ferreri, Christopher; Kalariya, Nilesh; Anderson, Larry D; Afrough, Aimaz; Dima, Danai; Khouri, Jack; McGuirk, Joseph; Locke, Fred; Baz, Rachid; Patel, Krina K; Alsina, Melissa.
Afiliación
  • Hashmi H; Medical University of South Carolina.
  • Hansen DK; H. Lee Moffitt Cancer Center and Research Institute.
  • Peres LC; H. Lee Moffitt Cancer Center and Research Institute.
  • Puglianini OC; H. Lee Moffitt Cancer Center and Research Institute.
  • Freeman C; H. Lee Moffitt Cancer Center and Research Institute.
  • De Avila G; H. Lee Moffitt Cancer Center and Research Institute.
  • Sidana S; Stanford University School of Medicine.
  • Shune L; The University of Kansas Medical Center.
  • Sborov DW; The University of Utah Huntsman Cancer Institute.
  • Davis J; Medical University of South Carolina.
  • Wagner C; The University of Utah Huntsman Cancer Institute.
  • Kocoglu MH; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.
  • Atrash S; Levine Cancer Institute.
  • Voorhees P; Levine Cancer Institute.
  • Simmons G; Virginia Commonwealth University Massey Cancer Center.
  • Ferreri C; The University of Texas MD Anderson Cancer Center.
  • Kalariya N; The University of Texas MD Anderson Cancer Center.
  • Anderson LD; UT Southwestern Harold C. Simmons Comprehensive Cancer Center.
  • Afrough A; UT Southwestern Harold C. Simmons Comprehensive Cancer Center.
  • Dima D; Cleveland Clinic, Cleveland, OH.
  • Khouri J; Cleveland Clinic, Cleveland, OH.
  • McGuirk J; The University of Kansas Medical Center.
  • Locke F; H. Lee Moffitt Cancer Center and Research Institute.
  • Baz R; H. Lee Moffitt Cancer Center and Research Institute.
  • Patel KK; The University of Texas MD Anderson Cancer Center.
  • Alsina M; H. Lee Moffitt Cancer Center and Research Institute.
Haematologica ; 2023 10 19.
Article en En | MEDLINE | ID: mdl-37855036

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article